Arca
Skip to content
Tools
Tools

Voltage-activated calcium channel beta 2 subunit

Protein in Schistosoma mansoni that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Praziquantel

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        PraziquantelApprovedBayerSmall moleculeBlockerVoltage-activated calcium channel beta 2 subunit blocker6

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 6 in all, from ClinicalTrials.gov.
        A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female Genital SchistosomiasisPraziquantelPhase 3Not yet recruitingBrian NgwiraNov 4, 2026
        Different Treatment Frequencies for Hepatic Fibrosis Due to SchistosomiasisPraziquantelPhase 2 / Phase 3Not yet recruitingRhode Island HospitalAug 10, 2026
        Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsPraziquantelNot applicableRecruitingUwemedimo Friday EkpoJul 16, 2026
        Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and PraziquantelPraziquantelNot applicableRecruitingFirst Affiliated Hospital of Guangxi Medical UniversityJul 20, 2025
        Oxfendazole in Mild Parenchymal Brain CysticercosisPraziquantelPhase 2 / Phase 3Not yet recruitingUniversidad Peruana Cayetano HerediaAug 22, 2024
        Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal NeurocysticercosisPraziquantelPhase 4Not yet recruitingR-Evolution Worldwide S.r.l. Impresa SocialeApr 19, 2024

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363080, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.